CCEL Cryo-Cell International, Inc. Quick Ratio

This daily price chart for Cryo-Cell International (CCEL) reflects the current 0.79. Business stability is supported by brand authority and high customer switching costs. The operating model relies on a proprietary cryobank, utilizing third-party services solely for the delivery of biomaterials. Cryo-Cell International (CCEL) generates revenue from its umbilical cord blood freezing service while continuously refining tissue preservation methods.

Cryo-Cell International maintains high operational flexibility by optimizing costs through the outsourcing of IT and logistics. The quick liquidity trajectory reflects the business's ability to cover short-term obligations solely through cash and accounts receivable, ignoring less liquid inventories, which allows investors to assess real financial stability and the efficiency of working capital management.